Preoperative Antihypertensive Medication in Relation to Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: A Meta-Analysis

• Published in: BioMed research international 2017-01, Vol.2017 (2017), p.1-12
• Main Authors: Zhang, Xiong-fei, Chen, An-ji, Pan, Dao-Bo, Wang, Xian-Xue, Zhou, Ai-Guo, Deng, Hui-Wei
• Format: Article
• Language: English
• Subjects: Adrenergic beta-Antagonists - therapeutic use; Analysis; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antihypertensive drugs; Atrial fibrillation; Atrial Fibrillation - classification; Atrial Fibrillation - physiopathology; Atrial Fibrillation - therapy; Calcium Channel Blockers - therapeutic use; Cardiac arrhythmia; Cardiac Surgical Procedures; Clinical Trials as Topic; Dosage and administration; Drug therapy; Female; Health risk assessment; Heart; Humans; Hypertension - complications; Hypertension - physiopathology; Hypertension - therapy; Male; Meta-analysis; Methods; Preoperative Care; Prevention; Review; Studies; Surgery
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2017/1203538

Background. We undertake a systematic review and meta-analysis to evaluate the effect of preoperative hypertension and preoperative antihypertensive medication to postoperative atrial fibrillation (POAF) in patients undergoing cardiac surgery. Methods. We searched PubMed, Embase, and Cochrane Library (from inception to March 2016) for eligible studies. The outcomes were the effects of preoperative hypertension, preoperative calcium antagonists regimen, preoperative ACE inhibitors regimen, and preoperative beta blocking agents regimen with POAF. We calculated pooled risk ratios (OR) and 95% CIs using random- or fixed-effects models. Results. Twenty-five trials involving 130087 patients were listed. Meta-analysis showed that the number of preoperative hypertension patients in POAF group was significantly higher ( P < 0.05 ), while we found that there are no significant differences between two groups in Asia patients by subgroup analysis, which is in contrast to other outcomes. Compared with the Non-POAF group, the number of patients who used calcium antagonists and ACE inhibitors preoperatively in POAF group was significantly higher ( P < 0.05 ). And we found that there were no significant differences between two groups of preoperative beta blocking agents used ( P = 0.08 ). Conclusions. Preoperative hypertension and preoperative antihypertensive medication in patients undergoing cardiac operations seem to be associated with higher risk of POAF.